The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis

The 21-gene recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit in early estrogen receptor-positive (ER +) HER2-negative (HER2-) breast cancer (BCA). We evaluated clinicopathologic characteristics, RS and chemotherapy benefit in invasive ductal carcinoma (IDC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Makower, Della, Qin, Jiyue, Lin, Juan, Xue, Xiaonan, Sparano, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758772/
https://www.ncbi.nlm.nih.gov/pubmed/35027533
http://dx.doi.org/10.1038/s41523-021-00368-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758772/
https://www.ncbi.nlm.nih.gov/pubmed/35027533
http://dx.doi.org/10.1038/s41523-021-00368-9

Ejemplares similares